Universal versus Risk-Based Management of Unknown Group B Streptococcus Status at TermFunding No funding was secured for this study.
18 March 2019
14 May 2019
30 September 2019 (online)
Objectives This article estimates and compares public health costs of universal versus risk-based intrapartum antibiotic prophylaxis (IAP) administration for women with unknown Group B streptococcus (GBS) status at term.
Study Design The annual number of women in the U.S. who are: unscreened for GBS, without risk factors, delivering vaginally, multiparous, and eligible for discharge within 24 hours was estimated. Under the risk-based strategy, women and neonates were assumed to stay another day for observation and incur the cost of an additional 24-hour stay. With universal IAP administration, women delivering without complications were assumed to be discharged within 24 hours, with an incurred cost of penicillin.
Results The estimated cost for the risk-based management of unscreened women at term without rupture of membranes (ROM) > 18 hours ranged from $468,886,831 to $850,556,179. Similarly, the cost of managing unscreened women without maternal intrapartum fever (MIF) ranged from $742,024,791 to $919,269,233. Alternatively, universal IAP administration costs ranged from $470,107,674 to $568,359,086.5. Cost comparisons yielded an equivalence or up to a 33.2% reduction in cost, and 36.6 to 38.2% reduction in cost for women without ROM > 18 hours and MIF, respectively.
Conclusions Universal IAP may be cost saving due to the reduction in extended hospitalizations for neonates and healthy mothers.
Keywordsearly-onset Group B streptococcus (EOGBS) - intrapartum antibiotic prophylaxis - risk-based management of GBS - universal management of GBS - neonatal sepsis - prelabor rupture of membranes - maternal intrapartum fever
The authors have no financial relationships relevant to this article to disclose.
- 1 American College of Obstetricians and Gynecologists Committee on Obstetric Practice. ACOG Committee Opinion No. 485: prevention of early-onset group B streptococcal disease in newborns. Obstet Gynecol 2011; 117 (04) 1019-1027
- 2 Verani JR, McGee L, Schrag SJ. ; Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention (CDC). Prevention of perinatal group B streptococcal disease--revised guidelines from CDC, 2010. MMWR Recomm Rep 2010; 59 (RR-10): 1-36
- 3 Baker CJ, Byington CL, Polin RA. ; Committee on Infectious Diseases; Committee on Fetus and Newborn. Policy statement—recommendations for the prevention of perinatal group B streptococcal (GBS) disease. Pediatrics 2011; 128 (03) 611-616
- 4 Picchiassi E, Coata G, Babucci G. , et al. Intrapartum test for detection of Group B Streptococcus colonization during labor. J Matern Fetal Neonatal Med 2018; 31 (24) 3293-3300
- 5 Barber EL, Funai EF, Bracken MB, Illuzzi JL. Interpretation of 2002 Centers for Disease Control guidelines for group B streptococcus and evolving provider practice patterns. Am J Perinatol 2011; 28 (02) 97-102
- 6 Cheng PJ, Chueh HY, Liu CM, Hsu JJ, Hsieh TT, Soong YK. Risk factors for recurrence of group B streptococcus colonization in a subsequent pregnancy. Obstet Gynecol 2008; 111 (03) 704-709
- 7 Apgar BS, Greenberg G, Yen G. Prevention of group B streptococcal disease in the newborn. Am Fam Physician 2005; 71 (05) 903-910
- 8 Tam T, Bilinski E, Lombard E. Recolonization of group B Streptococcus (GBS) in women with prior GBS genital colonization in pregnancy. J Matern Fetal Neonatal Med 2012; 25 (10) 1987-1989
- 9 Nanduri SA, Petit S, Smelser C. , et al. Epidemiology of invasive early-onset and late-onset Group B streptococcal disease in the United States, 2006 to 2015: multistate laboratory and population-based surveillance. JAMA Pediatr 2019; 173 (03) DOI: 10.1001/jamapediatrics.2018.4826.
- 10 Zuppa AA, Alighieri G, Fracchiolla A. , et al. Effectiveness of a prematurity-based protocol for management of infants born to mothers with Group B Streptococcus colonisation. J Obstet Gynaecol 2014; 34 (08) 673-678
- 11 Gilson GJ, Christensen F, Romero H, Bekes K, Silva L, Qualls CR. Prevention of group B streptococcus early-onset neonatal sepsis: comparison of the Center for Disease Control and prevention screening-based protocol to a risk-based protocol in infants at greater than 37 weeks' gestation. J Perinatol 2000; 20 (8 Pt 1): 491-495
- 12 Berger MB, Xu X, Williams JA, Van de Ven CJ, Mozurkewich EL. Early hospital discharge of infants born to group B streptococci-positive mothers: a decision analysis. BJOG 2012; 119 (04) 439-448
- 13 Husereau D, Drummond M, Petrou S. , et al; ISPOR Health Economic Evaluation Publication Guidelines-CHEERS Good Reporting Practices Task Force. Consolidated Health Economic Evaluation Reporting Standards (CHEERS)—explanation and elaboration: a report of the ISPOR Health Economic Evaluations Publication Guidelines Good Reporting Practices Task Force. Value Health 2013; 16 (02) 231-250
- 14 Van Dyke MK, Phares CR, Lynfield R. , et al. Evaluation of universal antenatal screening for group B streptococcus. N Engl J Med 2009; 360 (25) 2626-2636
- 15 Martin JA, Hamilton BE, Osterman MJK, Driscoll AK, Drake P. Births: final data for 2016. Natl Vital Stat Rep 2018; 67 (01) 1-55
- 16 Makhoul IR, Sprecher H, Smolkin T. , et al. Approach to term neonates born after maternal intrapartum fever and unknown maternal group B Streptococcus status: value of serum C-reactive protein and 16S rRNA gene PCR amplification. Pediatr Infect Dis J 2007; 26 (11) 1064-1066
- 17 Pasko DN, McGee P, Grobman WA. , et al; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Maternal-Fetal Medicine Units (MFMU) Network. Variation in the nulliparous, term, singleton, vertex cesarean delivery rate. Obstet Gynecol 2018; 131 (06) 1039-1048
- 18 Lexicomp. 2019 . Penicillin G (intravenous and short-acting intramuscular): Drug information. Lexicomp, UpToDate. Available at: https://www-uptodate-com.ezproxy.library.unlv.edu/contents/penicillin-g-intravenous-and-short-acting-intramuscular-drug-information?search=U.S.%20cost%20of%20penicillin%20G&source=search_result&selectedTitle=7~150&usage_type=default&display_rank=7#F16323647 . Accessed April 14, 2019
- 19 Podulka J, Stranges E, Steiner C. Hospitalizations Related to Childbirth, 2008 : Statistical Brief #110. Healthcare Cost and Utilization Project (HCUP) Statistical Briefs. Rockville, MD: Agency for Healthcare Research and Quality (US); 2006–2011 April
- 20 Bromberger P, Lawrence JM, Braun D, Saunders B, Contreras R, Petitti DB. The influence of intrapartum antibiotics on the clinical spectrum of early-onset group B streptococcal infection in term infants. Pediatrics 2000; 106 (2 Pt 1): 244-250
- 21 Benahmed N, San Miguel L, Devos C, Fairon N, Christiaens W. Vaginal delivery: how does early hospital discharge affect mother and child outcomes? A systematic literature review. BMC Pregnancy Childbirth 2017; 17 (01) 289
- 22 Di Renzo GC, Melin P, Berardi A. , et al. Intrapartum GBS screening and antibiotic prophylaxis: a European consensus conference. J Matern Fetal Neonatal Med 2015; 28 (07) 766-782
- 23 Pulver LS, Hopfenbeck MM, Young PC. , et al. Continued early onset group B streptococcal infections in the era of intrapartum prophylaxis. J Perinatol 2009; 29 (01) 20-25 . Doi: 10.1038/jp.2008
- 24 Smaill FM. Intrapartum antibiotics for Group B streptococcal colonisation. Cochrane Database Syst Rev 2004; (03) CD000115
- 25 Benitz WE, Gould JB, Druzin ML. Antimicrobial prevention of early-onset group B streptococcal sepsis: estimates of risk reduction based on a critical literature review. Pediatrics 1999; 103 (06) e78
- 26 Centers for Disease Control and Prevention (CDC). Trends in perinatal group B streptococcal disease - United States, 2000-2006. MMWR Morb Mortal Wkly Rep 2009; 58 (05) 109-112
- 27 Solensky R. Penicillin allergy: immediate reactions. In: Feldweg AM. , ed. UpToDate. 2019 . Available at: https://www-uptodate-com.ezproxy.library.unlv.edu/contents/penicillin-allergy-immediate-reactions?search=cost%20of%20penicillin%20admin%20to%20prevent%20EOGBS&topicRef=438&source=see_link . Accessed April 15, 2019
- 28 Bhattacharya S. The facts about penicillin allergy: a review. J Adv Pharm Technol Res 2010; 1 (01) 11-17
- 29 Baker CJ. Neonatal group B streptococcal disease: prevention. In: Barss VA. , ed. UpToDate. 2019. Available at: https://www-uptodate-com.ezproxy.library.unlv.edu/contents/neonatal-group-b-streptococcal-disease-prevention?search=cost%20of%20penicillin%20used%20in%20EOGBS&source=search_result&selectedTitle=18~150&usage_type=default&display_rank=18#H13 . Accessed April 15, 2019
- 30 Lexicomp. Cefazolin: Drug Information. Lexicomp, UpToDate. 2019. Available at: https://www-uptodate-com.ezproxy.library.unlv.edu/contents/cefazolin-drug-information?search=united%20states%20cost%20of%20cefazolin%20lexicomp&source=search_result&selectedTitle=6~150&usage_type=default&display_rank=6#F16323045 . Accessed April 15, 2019
- 31 Lexicomp. Vancomycin: Drug information. Lexicomp, UpToDate. 2019. Available at: https://www-uptodate-com.ezproxy.library.unlv.edu/contents/vancomycin-drug-information#F233317 . Accessed April 15, 2019
- 32 Lexicomp. Clindamycin (systemic): Drug information. Lexicomp, UpToDate. 2019. Available at: https://www-uptodate-com.ezproxy.library.unlv.edu/contents/clindamycin-systemic-drug-information#F8008170 . Accessed April 16, 2019
- 33 Hays C, Louis M, Plainvert C. , et al. Changing epidemiology of Group B streptococcus susceptibility to fluoroquinolones and aminoglycosides in France. Antimicrob Agents Chemother 2016; 60 (12) 7424-7430
- 34 Bizzarro MJ, Dembry LM, Baltimore RS, Gallagher PG. Changing patterns in neonatal Escherichia coli sepsis and ampicillin resistance in the era of intrapartum antibiotic prophylaxis. Pediatrics 2008; 121 (04) 689-696
- 35 Schuchat A, Zywicki SS, Dinsmoor MJ. , et al. Risk factors and opportunities for prevention of early-onset neonatal sepsis: a multicenter case-control study. Pediatrics 2000; 105 (1 Pt 1): 21-26
- 36 Kowlessar N, Jiang H, Steiner C. Hospital Stays for Newborns, 2011: Statistical Brief #163–Healthcare Cost and Utilization Project (HCUP) Statistical Briefs. Rockville, MD: Agency for Healthcare Research and Quality (US); 2006. –2013
- 37 Coin News Media Group LLC. US Inflation Calculator. Available at: https://www.usinflationcalculator.com . Accessed April 14, 2019